Medifast surges on Q2 earnings beat as turnaround gains traction
The stock price surged due to heightened expectations of a turnaround following strong performance (Q2 earnings beat).
The current stock price has surpassed the previous resistance level of $11.16, indicating that it has entered a new upward phase, prompting us to consider a purchase. We made this decision to enter at this point based on the candlestick movement and indicators following the positive earnings news.
If an additional upward trend continues and establishes a new bullish phase by surpassing the previous resistance level of $11.16, I will respond around the take-profit target of $11.16. Conversely, if downward pressure increases and it breaks below the support level of $9.39, I will immediately cut losses at the stop-loss price of $9.39.
The RSI(14) is at 34.9, approaching an oversold condition, and the moving averages are in a non-aligned state. The trading volume is 1.49 times the 20-day average, and the recent 7-day volatility is +3.1%.
Past similar success cases include BLMN, which recorded a 36.3% return on 2026-08-05, APPS, which recorded a 36.2% return on 2026-08-05, and EMBC, which recorded a 33.3% return on 2026-08-07. All of these cases share the common keyword 'earnings beat,' providing a basis for selection that can be referenced in the context of the current positive performance news for MED.
Based on positive earnings news and expectations of breaking through resistance levels, I initiated a buy position; however, the outcome was a failure, reaching the stop-loss at a -10.4% loss. At the time of entry, I anticipated a rebound momentum due to the oversold condition with an RSI(14) of 34.9 and a 1.49 times increase in trading volume, but the downward trend indicated by the misaligned moving averages was not sufficiently overcome.
Through this experience, it has been confirmed that even in the presence of positive news or attempts to break resistance levels, risk management should be applied more conservatively in a phase where the overall moving averages are misaligned and a downward trend is dominant. In future trading, I will more rigorously assess the alignment of technical indicators and the possibility of breaching support levels before entering positions.